PAPER
Aryl Azides from Aryl Amines under Neutral Conditions
1805
13C NMR (DMSO-d6): d = 153.7 (d, J = 248 Hz), 140.9, 139.4 (d,
J = 10 Hz), 131.2 (d, J = 7.5 Hz), 125.8 (d, J = 1.5 Hz), 124.8 (d,
J = 10 Hz), 115.9 (d, J = 3.5 Hz), 108.1 (d, J = 2.5 Hz), 107.6.
mL), t-BuONO (0.74 mL, 3.72 mmol) and t-BuOH (0.3 mL) as sol-
vent, the title compound was obtained.
Yield: 65 mg (60%); liquid.
IR (KBr): 2115 (s), 1521 (s) cm–1.
MS: m/z = 204 (M+ + 1), 178.
Anal. Calcd for C9H6FN5: C, 53.19; H, 2.98; N, 34.47. Found: C,
53.10; H, 3.02, 34.66.
1H NMR (CDCl3): d = 7.70 (s, 1 H), 7.36 (t, J = 8.3 Hz, 1 H), 7.11
(s, 1H), 6.91–6.96 (m, H), 4.76 (s, 2 H), 0.94 (s, 9 H), 0.13 (s, 6 H).
13C NMR (CDCl3): d = 155.4 (d, J = 251.1 Hz), 143.7, 140.8 (d,
J = 10 Hz), 136.5 (d, J = 4.1 Hz), 126 (d, J = 1.9 Hz), 116.4 (d,
J = 2.2 Hz), 115.4 (d, J = 3.4 Hz), 108.4, 107.9, 60.1, 25.9, 18.4,
–5.3.
4-(4-Azido-2-fluorophenyl)morpholine (Entry 16)
Using the general procedure, with 4-(4-amino-2-fluorophenyl)mor-
pholine (500 mg, 2.55 mmol), sodium azide (497 mg, 7.65 mmol),
H2O (382 mL), t-BuONO (3.03 mL, 15.3 mmol) and t-BuOH (2.5
mL) as solvent, the title compound was obtained,
MS: m/z = 348 (M+ + 1), 307, 238.
Yield: 340 mg (60%); brown semi-solid.
IR (neat): 2113 (s) cm–1.
Anal. Calcd for C16H22FN5OSi: C, 55.31; H, 6.38; N, 20.16. Found:
C, 55.49; H, 6.36; N, 20.02.
1H NMR (CDCl3): d = 6.95–6.65 (m, 2 H), 6.48–6.32 (m, 1 H),
tert-Butyl 4-(4-Azido-2-fluorophenyl)piperazine-1-carboxylate
(Entry 20)
Using the general procedure with an exception (reaction carried out
at 70 °C), with tert-butyl 4-(4-amino-2-fluorophenyl)piperazine-1-
carboxylate (3.0 g, 10.2 mmol), sodium azide (2.0 g, 30.6 mmol),
H2O (1.5 mL), t-BuONO (24.2 mL, 122.4 mmol) and t-BuOH (10
mL) as solvent, the title compound was obtained.
3.95–3.75 (br s, 4 H), 3.10–3.01 (m, 2 H), 3.00–2.88 (m, 2 H).
13C NMR (CDCl3): d = 158.5 (d, J = 250 Hz), 137.2 (d, J = 8.7),
134.5 (d, J = 10 Hz), 119.6 (d, J = 4.2 Hz), 114.8 (d, J = 3.0 Hz),
107.7 (d, J = 24.3 Hz), 66.9, 51.0 (d, J = 3.5 Hz).
MS: m/z = 223 (M+ + 1), 208, 194, 163, 136, 103.
Anal. Calcd for C10H11FN4O: C, 54.05; H, 4.99; N, 25.21. Found:
C, 53.87; H, 4.76; N, 25.11.
Yield: 2.3 g (70%); yellow solid; mp 58–60 °C.
IR (KBr): 2115 (m), 1686 (w) cm–1.
4-(4-Azido-2,6-difluorophenyl)morpholine (Entry 17)
Using the general procedure, with 4-(4-amino-2,6-difluorophe-
nyl)morpholine (500 mg, 2.34 mmol), sodium azide (456 mg, 7.02
mmol), H2O (350 mL), t-BuONO (2.78 mL, 14 mmol) and t-BuOH
(2.5 mL) as solvent, the title compound was obtained.
1H NMR (CDCl3): d = 6.91 (t, J = 8.8 Hz, 1 H), 6.78–6.72 (m, 2 H),
3.59 (t, J = 4.8 Hz, 4 H), 2.98 (t, J = 4.8 Hz, 4 H), 1.48 (s, 9 H).
13C NMR (CDCl3): d = 156.6 (d, J = 200 Hz), 153.7 (d, J = 6.5 Hz),
135.9 (dd, J = 10, 120 Hz), 120.1 (d, J = 5.5 Hz), 114.8 (d, J = 3
Hz), 107.7 (d, J = 25 Hz), 79.8, 50.6, 43.7, 28.4.
Yield: 359 mg (64%); brown solid; mp 69–70 °C.
IR (KBr): 2121 (s) cm–1.
1H NMR (CDCl3): d = 6.55 (d, J = 9.4 Hz, 2 H), 3.80 (t, J = 4.3 Hz,
4 H), 3.15 (t, J = 4.3 Hz, 4H).
MS: m/z = 322 (M+ + 1), 293, 266, 237.
Anal. Calcd for C15H20FN5O2: C, 56.05; H, 6.28; N, 21.79. Found:
C, 55.89; H, 6.16; N, 21.87.
13C NMR (DMSO-d6): d = 158.0 (dd, J = 9, 247 Hz), 136.1 (t,
J = 13 Hz), 124.1 (t, J = 13.5 Hz), 104.0 (m), 66.7, 51.1 (t, J = 3
Hz).
1-Acetyl-4-(4-azido-2-fluorophenyl)piperazine (Entry 21)
Using the general procedure, with 1-[4-(4-amino-2-flurorophe-
nyl)piperazin-1-yl]ethanone (100 mg, 0.42 mmol), sodium azide
(82 mg, 1.26 mmol), H2O (63 mL), t-BuONO (1 mL, 5.0 mmol) and
t-BuOH (0.5 mL) as solvent, the title compound was obtained.
MS: m/z = 241 (M+ + 1), 215, 200, 169, 113, 97.
Anal. Calcd for C10H10F2N4O: C, 49.98; H, 4.20; N, 23.32. Found:
C, 50.10; H, 4.28; N, 23.39.
Yield: 75 mg (68%); orange solid; mp 108–110 °C.
IR (KBr): 2116 (m), 1647 (m), 1508 (s) cm–1.
4-(5-Azidopyridin-2-yl)morpholine (Entry 18)
1H NMR (CDCl3): d = 6.95–6.67 (m, 3 H), 3.83–3.70 (m, 2 H),
Using the general procedure, with 4-(5-aminopyridin-2-yl)morpho-
line (500 mg, 2.79 mmol), sodium azide (544 mg, 8.37 mmol), H2O
(418 mL), t-BuONO (6.6 mL, 33.5 mmol) and DMF (3 mL) as sol-
vent, the title compound was obtained.
3.68–3.55 (m, 2 H), 3.08–2.94 (m, 4 H), 2.14 (s, 3 H).
13C NMR (CDCl3): d = 168.9, 156.0 (d, J = 250 Hz), 135.6 (dd,
J = 10, 85 Hz), 120.2 (d, J = 4 Hz), 114.8 (d, J = 3.5 Hz), 107.7 (d,
J = 25 Hz), 51.0 (d, J = 3 Hz), 50.4 (d, J = 3 Hz), 46.3, 41.4, 21.2.
Yield: 287 mg (50%); brown solid; mp 60–62 °C.
IR (KBr): 2097 (s) cm–1.
1H NMR (CDCl3): d = 7.96 (d, J = 2.4 Hz, 1 H), 7.22 (dd, J = 2.9,
9.2 Hz, 1 H), 6.64 (d, J = 8.8 Hz, 1 H), 3.82 (t, J = 4.9 Hz, 4 H), 3.46
(t, J = 4.9 Hz, 4 H).
13C NMR (CDCl3): d = 157.2, 138.8, 128.3, 127.1, 107.1, 66.6, 45.8.
MS: m/z = 206 (M+ + 1), 178, 150.
MS: m/z = 264 (M+ + 1), 235, 223.
Anal. Calcd for C12H14FN5O: C, 54.75; H, 5.36; N, 26.60. Found:
C, 54.42; H, 5.21; N, 26.71.
1-(4-Azido-2-fluorophenyl)-4-methylsulfonylpiperazine (Entry
22)
Using the general procedure, with 3-fluoro-4-(4-methylsulfonylpip-
erazin-1-yl)phenylamine (100 mg, 0.37 mmol), sodium azide (72
mg, 1.1 mmol), H2O (111 mL), t-BuONO (0.9 mL, 4.44 mmol) and
t-BuOH (0.4 mL) as solvent, the title compound was obtained.
Anal. Calcd for C9H11N5O: C, 52.66; H, 5.41; N, 34.13. Found: C,
52.83; H, 5.41; N, 34.01.
Yield: 70 mg (64%); yellow solid; mp 118–120 °C.
IR (KBr): 2118 (m) cm–1.
1-(4-Azido-2-fluorophenyl)-4-(tert-butyldimethylsilanyloxy-
methyl)-1H-imidazole (Entry 19)
Using the general procedure at 70 °C, with 1-(4-amino-2-fluo-
rophenyl)-4-(tert-butyldimethylsilanyloxymethyl)-1H-imidazole
(100 mg, 0.31 mmol), sodium azide (60 mg, 0.93 mmol), H2O (93
1H NMR (CDCl3): d = 7.10–6.82 (m, 2 H), 6.78–6.68 (m, 1 H),
3.46–3.28 (m, 4 H), 3.22–3.05 (m, 4 H), 2.83 (s, 3 H).
Synthesis 2005, No. 11, 1801–1806 © Thieme Stuttgart · New York